FDA Inspection 1203381 — ACS Dobfar S.p.A.

ACS Dobfar S.p.A. — FEI 3006028606

The FDA completed an inspection of ACS Dobfar S.p.A. on April 8, 2022 in Teramo, San Nicolo A Tordino. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 8, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Teramo, San Nicolo A Tordino (Italy)

Additional Details

Mutual Recognition Agreement (MRA)